Dr. Reddy’s intros OTC Allegra-D
Dr. Reddy’s is offering the first to market over-the-counter fexofenadine HCl 180 mg and pseudoephedrine HCl 240 mg extended-release tablets, a store-brand equivalent of Aventis’s Allegra-D 24 HR.
“The launch of Dr. Reddy’s fexofenadine HCl 180 mg and pseudoephedrine HCl 240 mg extended-release tablets is an important addition to our upper respiratory portfolio of OTC products,” said Marc Kikuchi, CEO of North America generics at Dr. Reddy’s. “This first-to-market launch is a testament to our deep capabilities and our continued efforts to bring high quality, affordable store-brand alternatives for our customers and patients.”
[Read more: Dr. Reddy's intros OTC naproxen sodium tablets]
Dr. Reddy’s product is an OTC oral antihistamine and nasal decongestant for the temporary relief of nasal and sinus congestion due to colds or allergies. It temporarily relieves sneezing; runny nose; itchy, watery eyes; and itchy nose or throat due to allergies, the company noted.
Allegra-D 24 HR had a market value of roughly $45 million as of May 2022, according to IRI.
Dr. Reddy’s OTC product will be available in 5-count, 10-count and 15-count pack sizes.